USPTO 2015–2025 USPTO PatentsView US Corporation

Curonix LLC

USPTO PatentsView assignee record - 19 granted patents across 11 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, Curonix ranks #15,211 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 11 technology areas.

#15,211
of 49,997 US assignees by volume
Top 8%
by Innovation Score (53.8/100)
19.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R15211 · US Corporation #15,211 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 19 grants
  • MID-PACK #15,211/49,997
  • PHOTO-FINISH Calyan
  • CPC-FOCUS A61N · 11 areas
  • INNOV-PAR 53.8/100
  • CLAIMS-RICH 19.6 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2023–2025 · 3y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Calyan Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Curonix’s 53.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Curonix

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Curonix's Innovation Score is 53.8/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Curonix?

Each dot is one of Curonix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Curonix’s own 19.6 claims/patent is ABOVE the 17.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Curonix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 18.918.91919.1 0510152025 Granted patents (volume) Avg claims / patent Cpsi Holdings LLC - 19, 18.05Cpsi HoldingsCrown Iron Works Company LLC - 19, 13.11Crown Iron WorksCSA Medical, Inc. - 19, 19.32CSA MedicalCSIdentity Corporation - 19, 19.26CsidentityCustom Wheel House, LLC - 19, 1.84Custom Wheel HouseCyberswitching Patents, LLC - 19, 17.47Cyberswitching Pa…Calyan Technologies, Inc. - 19, 22.42CalyanCardioFocus, Inc. - 19, 11.58CardiofocusCuronix LLC - 19, 19.58Curonix
Curonix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Curonix's grants concentrate

Curonix LLC is a focused PatentsView assignee: 11 CPC subclasses with 94.7% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2024 (9 grants) versus a trough of 4 in 2023. By volume, Curonix sits between Cpsi Holdings LLC and CardioFocus, Inc..

Curonix's three-year grant acceleration

Curonix LLC shows 13 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Curonix's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Curonix holds 19 patents at rank #15,191, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Curonix

By rank, the assignees closest to #15,191 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Curonix's primary technology class.

Curonix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

246810 202320242025 6
USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table
Curonix LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2023 4 21.1%
2024 9 47.4%
2025partial year 6 31.6%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Curonix LLC's patent record in context - here's where to go next.

  • Curonix LLC's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 94.7% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #15,211 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Curonix LLC against Cpsi Holdings LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 53.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.